The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials - The American

September 24,2024

Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art - ScienceDirect

Frontiers The potential of glucagon-like peptide-1 receptor agonists in heart failure

Tirzepatide Once Weekly for the Treatment of Obesity

Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review - You Deng, Andrew Park, Lin Zhu, Wen Xie, Calvin Q. Pan, 2022

How glucagon-like peptide 1 receptor agonists work in: Endocrine Connections Volume 10 Issue 7 (2021)

Association of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis - eClinicalMedicine

IJMS, Free Full-Text

Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes - ScienceDirect

Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications

Biomedicines, Free Full-Text

Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials